Investor RelationsPresseCOVID-19
  1. Home
  2. Medical Imaging
  3. Computertomographie
  4. CT Portfolio Highlights
  5. CT for Oncology

Computed Tomography for OncologyYou think ahead. We innovate ahead.

Cancer incidence is on the rise: by 2030, there will be almost 20 million new cases per year.1 Thanks to its ability to provide ever more detailed and precise images, Computed Tomography is a key player in the comprehensive management of cancer patients – from initial diagnosis to treatment planning, monitoring, and follow-up

You think ahead in advancing cancer care. We innovate ahead with technologies that support you throughout the entire patient pathway. Explore how it can help you provide state-of-the-art care to your oncology patients.

Innovating CT in oncology

Revolutionizing oncology with photon-counting CT

For accurate and precise imaging, NAEOTOM Alpha, the world’s first photon-counting CT, offers capabilities that could revolutionize oncology imaging in your institution. NAEOTOM Alpha provides precise and improved tissue differentiation with reduced radiation exposure. For lesion assessment, photon-counting CT can potentially change your patient pathway thanks to early detection and improved diagnostic accuracy. 

Listen to the talk by Bari Dane, MD, from NYU Langone Medical Center to learn more about the amazing potential of photon-counting CT.


Dual Energy – advanced oncology assessment with spectral imaging

Siemens Healthineers also builds on the strength of Dual Energy, which permits visualization, characterization, and quantification of various materials in greater detail than traditional scans. This is why our CT scanner portfolio is designed to have meaningful Dual Energy capabilities: fully integrated into the acquisition workflow without additional effort by operators – and offering PACS-ready results with customizable and fully automated reconstructions.

Learn more about how this technology can help you make confident diagnostic and treatment decisions.

1/4
High resolution01
Spectral information02
Sub-millimeter image quality01
Spectral imaging of pancreatic neuroendocrine tumors, MPR, cVRT and iodine maps.

Courtesy of Semmelweis University, Budapest, Hungary

High resolution

Spectral imaging and high resolution help confirm surgical resectability of pancreatic neuroendocrine tumors.

Spectral imaging of pancreatic neuroendocrine tumors, MPR, cVRT and iodine maps.
Clinical images, MPR, VNC, iodine maps: inherently available spectral information for incidental lesion evaluation.
Whole-body scan and liver staging with outstanding sub-millimeter image quality at low dose for oncology assessment
Whole-body scan and liver staging with outstanding sub-millimeter image quality at low dose for oncology assessment.
1/4

Advancing lung cancer screening with CT

In the case of lung cancer, early detection is absolutely crucial. Siemens Healthineers portfolio of CT scanners is optimized to help you accomplish just that. Our mobile solutions allow to bring lung cancer screening right to you, with a CT scanner that is installed inside a vehicle, trailer, or container. This helps improve access to care, for example in rural areas. Since lung cancer screening requires frequent CT scans, cumulative dose levels are a key consideration as well.
1/2
Dose matters 01
Tin Filter & dose01
Graph showing cumulative dose over a patient’s screening lifetime

Source: Sebastian Schmidt

Dose matters

Cumulative dose over a patient’s screening lifetime


Graph showing cumulative dose over a patient’s screening lifetime
Illustrated case study demonstrating the effect of Tin Filter technology to achieve low-dose lung imaging using the CT scanner SOMATOM go.Up
1/2

Tin Filter white paper 

White paper: Shaping the beam - Versatile filtration for unique diagnostic potential within Siemens Healthineers CT

Minimizing dose with Tin Filter

Our CT portfolio is equipped with Tin Filter: a unique technology that cuts out lower energies to reduce dose and optimize image quality. Download this white paper to learn more about the distinct benefits of this technology when it comes to detecting pulmonary nodules.

Boosting CT-guided interventions and radiation therapy with CT

Optimal support in CT-guided interventions 

Minimally invasive ablation procedures in cancer cases are projected to increase by 8% per year between 2020 and 2030.2 While biopsies will remain the core application, therapeutic procedures are expected to become much more important due to the obvious advantages of minimally invasive therapy: fewer complications, faster recovery times, and shorter hospital stays. Our portfolio of CT scanners and advanced technologies supports you in both routine and complex CT-guided interventions – helping you plan needle paths and providing visual guidance to help you reach the target area. Studies suggest that advanced technologies such as our integrated laser guidance system have the potential to increase efficiency, reduce radiation dose, and improve accuracy.3 Giving you full in-room control over relevant parameters, our solutions aim to streamline workflows and increase efficiency.

Tumor ablation workflow video 

Ralph Bauer, MD, uses SOMATOM go.Up with myNeedle Companion at his radiology practice in Wiesbaden, Germany.

Watch the video to learn how this solution helps him optimize patient treatment.

 

Optimizing treatment plans in radiation therapy

Around 40% of cancer patients will undergo radiation therapy as part of their cancer treatment.4 CT plays a pivotal role, as the CT planning image is the foundation of the whole radiation therapy workflow. Our portfolio for radiation therapy planning is optimally suited to help you achieve consistent imaging results even in moving anatomy. Thanks to Direct i4D technology, you can reduce breathing artifacts, capture detailed images of lesions, and ensure precise organ contouring with the support of AI tools.

1/2
Minimized motion artifacts 01
Precise contouring 01

Courtesy of University Clinic Hamburg Eppendorf, Hamburg, Germany

Minimized motion artifacts

85% reduction in image artifacts4
Compared to a standard 4D CT protocol

CT image with precisely contoured organs, demonstrating the benefits of using Intelligent 4D CT Sequence Scanning (i4DCT) technology
1/2
1
Data comes from the Global Cancer Observatory, owned by the World Health Organization/International Agency for Research on Cancer 
(https://www.wcrf.org/dietandcancer/worldwide-cancer-data/).
2
Siemens Healthineers evaluation based on Clarivate: Interventional Oncology Devices Market Insights, 2021.
3
Becker LS et al. Fully Integrated Laser Guidance for CT-Based Punctures: A Study in Phantoms and Patients. J Vasc Interv Radiol. 2023 Jan; 34(1):130-138.
4
Beaton L et al. How rapid advances in imaging are defining the future of precision radiation oncology. Br J Cancer. 2019 Apr;120(8):779-790.
5
Werner R et al. Intelligent 4D CT Sequence Scanning (i4DCT). Best of Physics, ASTRO 2018, Med. Phys. 46 (8) June 2019.
6
Clinical evaluation of 50 CT datasets for 5 sites with each 10 cases. 2140 OAR evaluated. Manual contouring, allowed for slice interpolation and contouring aids.)
The products/features and/or service offerings (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. 
SOMATOM go.Up syngo CT VB10 is pending 510(k) clearance, and is not yet commercially available in the United States and other countries. Please contact your local Siemens Healthineers organization for further details.
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Because there is no "typical" hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.